Advanced multiparametric magnetic resonance imaging of multinodular and vacuolating neuronal tumor.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
08 2020
Historique:
received: 23 01 2020
accepted: 10 04 2020
pubmed: 18 4 2020
medline: 22 6 2021
entrez: 18 4 2020
Statut: ppublish

Résumé

Multinodular and vacuolating neuronal tumor (MVNT) of the cerebrum is a rare brain lesion with suggestive imaging features. The aim of our study was to report the largest series of MVNTs so far and to evaluate the utility of advanced multiparametric magnetic resonance (MR) techniques. This multicenter retrospective study was approved by our institutional research ethics board. From July 2014 to May 2019, two radiologists read in consensus the MR examinations of patients presenting with a lesion suggestive of an MVNT. They analyzed the lesions' MR characteristics on structural images and advanced multiparametric MR imaging. A total of 64 patients (29 women and 35 men, mean age 44.2 ± 15.1 years) from 25 centers were included. Lesions were all hyperintense on fluid-attenuated inversion recovery and T2-weighted imaging without post-contrast enhancement. The median relative apparent diffusion coefficient on diffusion-weighted imaging was 1.13 [interquartile range (IQR), 0.2]. Perfusion-weighted imaging showed no increase in perfusion, with a relative cerebral blood volume of 1.02 (IQR, 0.05) and a relative cerebral blood flow of 1.01 (IQR, 0.08). MR spectroscopy showed no abnormal peaks. Median follow-up was 2 (IQR, 1.2) years, without any changes in size. A comprehensive characterization protocol including advanced multiparametric magnetic resonance imaging sequences showed no imaging patterns suggestive of malignancy in MVNTs. It might be useful to better characterize MVNTs.

Sections du résumé

BACKGROUND AND PURPOSE
Multinodular and vacuolating neuronal tumor (MVNT) of the cerebrum is a rare brain lesion with suggestive imaging features. The aim of our study was to report the largest series of MVNTs so far and to evaluate the utility of advanced multiparametric magnetic resonance (MR) techniques.
METHODS
This multicenter retrospective study was approved by our institutional research ethics board. From July 2014 to May 2019, two radiologists read in consensus the MR examinations of patients presenting with a lesion suggestive of an MVNT. They analyzed the lesions' MR characteristics on structural images and advanced multiparametric MR imaging.
RESULTS
A total of 64 patients (29 women and 35 men, mean age 44.2 ± 15.1 years) from 25 centers were included. Lesions were all hyperintense on fluid-attenuated inversion recovery and T2-weighted imaging without post-contrast enhancement. The median relative apparent diffusion coefficient on diffusion-weighted imaging was 1.13 [interquartile range (IQR), 0.2]. Perfusion-weighted imaging showed no increase in perfusion, with a relative cerebral blood volume of 1.02 (IQR, 0.05) and a relative cerebral blood flow of 1.01 (IQR, 0.08). MR spectroscopy showed no abnormal peaks. Median follow-up was 2 (IQR, 1.2) years, without any changes in size.
CONCLUSIONS
A comprehensive characterization protocol including advanced multiparametric magnetic resonance imaging sequences showed no imaging patterns suggestive of malignancy in MVNTs. It might be useful to better characterize MVNTs.

Identifiants

pubmed: 32301260
doi: 10.1111/ene.14264
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1561-1569

Informations de copyright

© 2020 European Academy of Neurology.

Références

Huse JT, Edgar M, Halliday J, Mikolaenko I, Lavi E, Rosenblum MK. Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion: multinodular and vacuolating neuronal tumors. Brain Pathol 2013; 23: 515-524.
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl) 2016; 131: 803-820.
Nunes RH, Hsu CC, da Rocha AJ, et al. Multinodular and vacuolating neuronal tumor of the cerebrum: a new, “Leave Me Alone” lesion with a characteristic imaging pattern. Am J Neuroradiol 2017; 38: 1899-1904.
Alsufayan R, Alcaide-Leon P, de Tilly LN, Mandell DM, Krings T. Natural history of lesions with the MR imaging appearance of multinodular and vacuolating neuronal tumor. Neuroradiology 2017; 59: 873-883.
Badat N, Savatovsky J, Charbonneau F, Collin A, Lecler A. Multinodular vacuolating and neuronal tumor of the cerebrum. Neurology 2017; 89: 304-305.
Shitara S, Tokime T, Akiyama Y. Multinodular and vacuolating neuronal tumor: a case report and literature review. Surg Neurol Int 2018; 9: 63.
Gonzalez-Quarante LH, Ruiz-Juretschke F, Sola Vendrell E, et al. Multinodular and vacuolating neuronal tumor of the cerebrum. A rare entity. New case and review of the literature. Neurocirugía 2018; 29: 44-55.
Makrakis D, Veneris S, Papadaki E. Multinodular and vacuolating neuronal tumor incidentally discovered in a young man: conventional and advanced MRI features. Radiol Case Rep 2018; 13: 960-964.
Fukushima S, Yoshida A, Narita Y, et al. Multinodular and vacuolating neuronal tumor of the cerebrum. Brain Tumor Pathol 2015; 32: 131-136.
Monté A-SMC, D’Arco F, De Cocker LJL. Multinodular and vacuolating neuronal tumor in an adolescent with Klinefelter syndrome. Neuroradiology 2017; 59: 1187-1188.
Johnson DR, Guerin JB, Giannini C, Morris JM, Eckel LJ, Kaufmann TJ. 2016 updates to the WHO brain tumor classification system: what the radiologist needs to know. Radiographics 2017; 37: 2164-2180.
Lecler A, Bailleux J, Carsin B, et al. Multinodular and vacuolating posterior fossa lesions of unknown significance. AJNR Am J Neuroradiol 2019; 40: 1689-1684.
Lecler A, Chauvet D, Biassette HA, Savatovsky J. Multiparametric imaging improves confidence in the diagnosis of multinodular and vacuolating neuronal tumor of the cerebrum. AJNR Am J Neuroradiol 2018; 39: E32-E33.
Choi E, Kim S-I, Won J-K, et al. Clinicopathological and molecular analysis of multinodular and vacuolating neuronal tumors of the cerebrum. Hum Pathol 2018; 86: 203-212.
Calderon-Garcidueñas AL, Mathon B, Lévy P, et al. New clinicopathological associations and histoprognostic markers in ILAE types of hippocampal sclerosis. Brain Pathol Zurich Switz 2018; 28: 644-655.
Thom M, Liu J, Bongaarts A, et al. Multinodular and vacuolating neuronal tumors in epilepsy: dysplasia or neoplasia?: MNVT: dysplasia or neoplasia. Brain Pathol 2018; 28: 155-171.
Yamaguchi M, Komori T, Nakata Y, Yagishita A, Morino M, Isozaki E. Multinodular and vacuolating neuronal tumor affecting amygdala and hippocampus: a quasi-tumor? Pathol Int 2016; 66: 34-41.
Cathcart SJ, Klug JR, Helvey JT, L. White M, Gard AP, McComb RD. Multinodular and vacuolating neuronal tumor: a rare seizure-associated entity. Am J Surg Pathol 2017; 41: 1005-1010.
Gökçe E. Magnetic resonance imaging findings of two cases with multinodular and vacuolating neuronal tumor. Acta Neurol Belg 2017; 120: 457-461.
Nagaishi M, Yokoo H, Nobusawa S, et al. Localized overexpression of alpha-internexin within nodules in multinodular and vacuolating neuronal tumors: Expression of alpha-internexin in MVNT. Neuropathology 2015; 35: 561-568.
Lecler A, Balvay D, Cuenod C-A, et al. Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions. J Magn Reson Imaging JMRI 2019; 50: 1514-1525.
Baščarević V, Pejović AT, Ristić AJ, et al. Multinodular and vacuolating neuronal tumour of the cerebrum: a rare neuroimaging incidentaloma or a potentially treatable cause of focal epilepsy? Epileptic Disord 2019; 21: 209-214.
Galletto Pregliasco A, Collin A, Guéguen A, et al. Improved detection of new MS lesions during follow-up using an automated MR coregistration-fusion method. AJNR Am J Neuroradiol 2018; 39: 1226-1232.

Auteurs

A Lecler (A)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

V Broquet (V)

Department of Neuroradiology, CHU Lille, Lille, France.

J Bailleux (J)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

B Carsin (B)

Department of Radiology, CHRU de Rennes, Rennes, France.

H Adle-Biassette (H)

Department of Pathology, Lariboisière Hospital, Paris Diderot, Paris-Cité-Sorbonne University, Paris, France.

S Baloglu (S)

Department of Radiology, University Hospital of Strasbourg, Strasbourg, France.

G Forestier (G)

Department of Neuroradiology, CHU Limoges, Limoges, France.

F Bonneville (F)

Department of Neuroradiology, Hôpital Pierre-Paul-Riquet, CHU Purpan, Toulouse, France.

E Calvier (E)

Neurology Department, Hôpital René et Guillaume-Laënnec, CHU de Nantes, Saint-Herblain, France.

D Chauvet (D)

Department of Neurosurgery, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

P O Comby (PO)

Department of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, Dijon, France.

J P Cottier (JP)

Department of Radiology, CHRU de Tours, Tours, France.
Brain and Imaging laboratory, UMR U930, INSERM, François-Rabelais University, Tours, France.

F Cotton (F)

Service de Radiologie, Centre Hospitalier Lyon-Sud, 69495 Pierre-Bénite, Hospices Civils de Lyon, University Claude Bernard Lyon 1, Lyon, France.

R Deschamps (R)

Department of Neurology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

C Diard-Detoeuf (C)

Department of Neurology, CH Sainte-Perrine, Paris, France.

F Ducray (F)

Department of Neuro-oncology, Lyon French Reference Center of Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France.

C Drissi (C)

Faculté de Médecine de Tunis, Institut National de Neurologie, Service de Neuroradiologie, Université de Tunis El Manar, Tunis, Tunisia.

M Elmaleh (M)

Pediatric Radiology Department, Robert Debré Hospital, Paris, France.

J Farras (J)

Jordi Radiologia C/ de la Roda, Andorra la Vella, Andorra.

J Aguilar Garcia (J)

Neurology Department, Hôpital René et Guillaume-Laënnec, CHU de Nantes, Saint-Herblain, France.

E Gerardin (E)

Department of Neuroradiology and MRI, Rouen University Hospital, Rouen, France.

S Grand (S)

Neuroradiologie diagnostique et interventionnelle et IRM Nord 'Centre Hospitalier et Universitaire de Alpes Grenoble', Grenoble, France.

D C Jianu (DC)

Department of Neurology, Victor Babes University of Medecine and Pharmacy, Timisoara, Romania.

S Kremer (S)

Department of Radiology, University Hospital of Strasbourg, Strasbourg, France.

H Loiseau (H)

Service de Neurochirurgie, CHU de Bordeaux, Université de Bordeaux, Bordeaux, France.

N Magne (N)

Department of Neuroradiology and MRI, Rouen University Hospital, Rouen, France.

M Mejdoubi (M)

Department of Neuroradiology, University Hospital of Martinique, Fort-de-France, France.

A Moulignier (A)

Department of Neurology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

M Ollivier (M)

Service de Radiologie, Groupe Hospitalier Pellegrin, Bordeaux, France.

S Nagi (S)

Faculté de Médecine de Tunis, Institut National de Neurologie, Service de Neuroradiologie, Université de Tunis El Manar, Tunis, Tunisia.
Clinique les Berges du Lac, rue du Lac de Constance, Tunis, Tunisia.

M Rodallec (M)

Centre d'Imagerie Centre Cardiologique du Nord, CCN, Saint-Denis, France.

N Shor (N)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France.

T Tourdias (T)

Service de Neuroimagerie Diagnostique et Thérapeutique, CHU de Bordeaux et INSERM U1215, Université de Bordeaux, Bordeaux, France.

C Vandendries (C)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.
Centre d'Imagerie Médicale Paris 15ème, RMX, Paris, France.

R Anxionnat (R)

Service de Radiologie, CHU de Nancy, Nancy, France.

L Duron (L)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

J Savatovsky (J)

Department of Neuroradiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.
Centre d'Imagerie Paris 13, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH